Your browser doesn't support javascript.
loading
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.
Glodde, Nicole; Bald, Tobias; van den Boorn-Konijnenberg, Debby; Nakamura, Kyohei; O'Donnell, Jake S; Szczepanski, Sabrina; Brandes, Maria; Eickhoff, Sarah; Das, Indrajit; Shridhar, Naveen; Hinze, Daniel; Rogava, Meri; van der Sluis, Tetje C; Ruotsalainen, Janne J; Gaffal, Evelyn; Landsberg, Jennifer; Ludwig, Kerstin U; Wilhelm, Christoph; Riek-Burchardt, Monika; Müller, Andreas J; Gebhardt, Christoffer; Scolyer, Richard A; Long, Georgina V; Janzen, Viktor; Teng, Michele W L; Kastenmüller, Wolfgang; Mazzone, Massimiliano; Smyth, Mark J; Tüting, Thomas; Hölzel, Michael.
Afiliación
  • Glodde N; Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, 39120 Magdeburg, Germany; Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, 53105 Bonn, Germany; Unit for RNA Biology, Department of Clinical Chemistry and Cli
  • Bald T; Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, 39120 Magdeburg, Germany; Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, 53105 Bonn, Germany; Immunology in Cancer and Infection Laboratory, QIMR Berghofer
  • van den Boorn-Konijnenberg D; Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, 53105 Bonn, Germany.
  • Nakamura K; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
  • O'Donnell JS; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, The University of Queensland, Her
  • Szczepanski S; Department of Internal Medicine III, Hematology/Oncology/Rheumatology, University of Bonn, 53105 Bonn, Germany.
  • Brandes M; Department of Internal Medicine III, Hematology/Oncology/Rheumatology, University of Bonn, 53105 Bonn, Germany.
  • Eickhoff S; Laboratory for Cellular Interactions and Immunimaging, Institute of Experimental Immunology, University of Bonn, 53105 Bonn, Germany.
  • Das I; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia.
  • Shridhar N; Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, 39120 Magdeburg, Germany; Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, 53105 Bonn, Germany.
  • Hinze D; Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, 53105 Bonn, Germany.
  • Rogava M; Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, 39120 Magdeburg, Germany; Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, 53105 Bonn, Germany.
  • van der Sluis TC; Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, 39120 Magdeburg, Germany; Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, 53105 Bonn, Germany.
  • Ruotsalainen JJ; Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, 39120 Magdeburg, Germany; Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, 53105 Bonn, Germany.
  • Gaffal E; Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, 39120 Magdeburg, Germany; Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, 53105 Bonn, Germany.
  • Landsberg J; Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, 53105 Bonn, Germany.
  • Ludwig KU; Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany; Department of Genomics, Life & Brain Center, University of Bonn, 53127 Bonn, Germany.
  • Wilhelm C; Unit for Immunopathology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, 53105 Bonn, Germany.
  • Riek-Burchardt M; Institute of Molecular and Clinical Immunology, University of Magdeburg, 39120 Magdeburg, Germany.
  • Müller AJ; Institute of Molecular and Clinical Immunology, University of Magdeburg, 39120 Magdeburg, Germany; Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany.
  • Gebhardt C; Skin Cancer Unit, German Cancer Research Center, Heidelberg and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht Karl University of Heidelberg, 69121 Heidelberg, Germany.
  • Scolyer RA; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, NSW 2050, Australia; Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, NSW 2065, Australia.
  • Long GV; Melanoma Institute Australia and Sydney Medical School, The University of Sydney, Sydney, NSW 2065, Australia.
  • Janzen V; Department of Internal Medicine III, Hematology/Oncology/Rheumatology, University of Bonn, 53105 Bonn, Germany.
  • Teng MWL; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, The University of Queensland, Herston, QLD 4006, Australia.
  • Kastenmüller W; Laboratory for Cellular Interactions and Immunimaging, Institute of Experimental Immunology, University of Bonn, 53105 Bonn, Germany.
  • Mazzone M; Laboratory of Molecular Oncology and Angiogenesis, Vesalius Research Center, VIB, Leuven B3000, Belgium; Laboratory of Molecular Oncology and Angiogenesis, Vesalius Research Center, Department of Oncology, KU Leuven, Leuven B3000, Belgium.
  • Smyth MJ; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia; School of Medicine, The University of Queensland, Herston, QLD 4006, Australia.
  • Tüting T; Laboratory of Experimental Dermatology, Department of Dermatology, University of Magdeburg, 39120 Magdeburg, Germany; Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn, 53105 Bonn, Germany. Electronic address: thomas.tueting@med.ovgu.de.
  • Hölzel M; Unit for RNA Biology, Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, 53105 Bonn, Germany. Electronic address: michael.hoelzel@ukbonn.de.
Immunity ; 47(4): 789-802.e9, 2017 10 17.
Article en En | MEDLINE | ID: mdl-29045907
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-met / Inmunoterapia / Neoplasias Experimentales / Neutrófilos Tipo de estudio: Prognostic_studies Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-met / Inmunoterapia / Neoplasias Experimentales / Neutrófilos Tipo de estudio: Prognostic_studies Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2017 Tipo del documento: Article